Chemotherapy for oral and maxillofacial tumors: an update
- PMID: 24794265
- DOI: 10.1016/j.coms.2014.01.004
Chemotherapy for oral and maxillofacial tumors: an update
Abstract
Surgery is the primary intervention in oral and maxillofacial tumors and under ideal circumstances is curative. There is no evidence to support the use of induction or adjuvant chemotherapy in initial therapy of early stage tumors. Locally advanced tumors, non-resectable tumors as well as recurrence in early stage disease, need a multi-modality therapeutic approach involving chemotherapy. Palliative chemotherapy plays an important role in the treatment patients with metastatic oral and maxillofacial tumors. Chemotherapy and targeted agents plays an important role in the treatment of patients with rare oral and maxillofacial tumors such as sarcomas, lymphomas, and giant cell tumors.
Keywords: Chemotherapy; Locally advanced; Maxillofacial tumors; Oral cavity tumors; Squamous cell carcinoma.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
P-glycoprotein expression in squamous cell carcinoma of the oral and maxillofacial region.Chin J Dent Res. 2000 May;3(1):23-6. Chin J Dent Res. 2000. PMID: 11314336
-
[Role of magnetic resonance in the staging and post-chemotherapeutic follow-up of malignant maxillo-facial tumors].Radiol Med. 1988 Jan-Feb;75(1-2):88-93. Radiol Med. 1988. PMID: 3347789 Italian.
-
Combined modality treatment of oral and oropharyngeal cancer including neoadjuvant intraarterial cisplatin and radical surgery followed by concurrent radiation and chemotherapy with weekly docetaxel - three year results of a pilot study.J Craniomaxillofac Surg. 2002 Apr;30(2):112-20. doi: 10.1054/jcms.2002.0283. J Craniomaxillofac Surg. 2002. PMID: 12069515 Clinical Trial.
-
[Current role for induction chemotherapy in head and neck tumors].Laryngorhinootologie. 2008 Apr;87(4):237-43; discussion 244. doi: 10.1055/s-2007-995588. Laryngorhinootologie. 2008. PMID: 18365986 Review. German.
-
Induction chemotherapy response and recurrence rates in correlation with N0 or N+ stage in oral squamous cell cancer (OSCC).Cancer Metastasis Rev. 2010 Dec;29(4):607-11. doi: 10.1007/s10555-010-9259-7. Cancer Metastasis Rev. 2010. PMID: 20842409 Review.
Cited by
-
Low expression of miR-30a-5p induced the proliferation and invasion of oral cancer via promoting the expression of FAP.Biosci Rep. 2018 Jan 25;38(1):BSR20171027. doi: 10.1042/BSR20171027. Print 2018 Feb 28. Biosci Rep. 2018. Retraction in: Biosci Rep. 2024 Nov 27;44(11):BSR-2017-1027_RET. doi: 10.1042/BSR-2017-1027_RET. PMID: 29026005 Free PMC article. Retracted.
-
Cationic antimicrobial peptide NRC-03 induces oral squamous cell carcinoma cell apoptosis via CypD-mPTP axis-mediated mitochondrial oxidative stress.Redox Biol. 2022 Aug;54:102355. doi: 10.1016/j.redox.2022.102355. Epub 2022 May 28. Redox Biol. 2022. PMID: 35660629 Free PMC article.
-
PEGylated nano-graphene oxide as a nanocarrier for delivering mixed anticancer drugs to improve anticancer activity.Sci Rep. 2020 Feb 17;10(1):2717. doi: 10.1038/s41598-020-59624-w. Sci Rep. 2020. PMID: 32066812 Free PMC article.
-
MiR-375/SLC7A11 axis regulates oral squamous cell carcinoma proliferation and invasion.Cancer Med. 2017 Jul;6(7):1686-1697. doi: 10.1002/cam4.1110. Epub 2017 Jun 19. Cancer Med. 2017. PMID: 28627030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical